Stability of isoniazid in isoniazid syrup: Formation of hydrazine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 17, Issue 4-5, 1998, Pages 885-890

  Carlin, Alan ^a   Gregory, Norman ^b   Simmons, John ^b  

^a Center for Drug Evaluation and Research   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Capillary gas chromatography; Carcinogens; Electron capture detection; Hydrazine; Isoniazid; Tuberculosis

Indexed keywords

HYDRAZINE; ISONIAZID;

ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG STABILITY; ELECTRON CAPTURE DETECTION; PRIORITY JOURNAL; SYRUP;

ANTITUBERCULAR AGENTS; CHROMATOGRAPHY, GAS; DOSAGE FORMS; DRUG STABILITY; ISONIAZID; SENSITIVITY AND SPECIFICITY;

EID: 0032146580     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(98)00002-8     Document Type: Article

References (9)

1. [1] USP 23, United States Pharmacopeial Convention, 1995, p. 846.
2. [2] Merck Index 1th ed., Merck, Rahway, NJ, 1989, pp. 4689, 5068.
3. [3] J. Juhász, J. Balo, G. Kendrey, Z. Krebsforsch. 62 (1957) 188-196.
4. [4] J.C. Arcos, Y.T. Woo, M.F. Argus, D.Y. Lai, Chemical Induction of Cancer, Academic Press, New York, 1982, p. 363.
5. [5] G.L. Mandell, M.A. Sande, in: A.G. Gillman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), The Pharmacological Basics of Therapeutics, 8th ed., Pergamon, New York, 1990, pp. 1146-1149.
6. [6] The Merck Manual of Diagnosis and Therapy, 16th ed., Merck, Rahway, NJ, 1992, pp. 139-140.
7. [7] F. Matsui, D.L. Robertson, E.G. Lovering, J. Pharm. Sci. 12 (1983) 948-951.
8. [8] C. Biancifiori, J. Natl. Cancer Inst. 44 (1970) 943-953.
9. [9] D.W. Gaylor, R.L. Kodell, J. Environ. Pathol. Toxicol. 4 (1980) 305-312.